Jubilant Life Sciences Unit Signs US Deal, Shares Surge Over 10%

Jubilant Life Sciences shares gained more than 10 per cent amid high volumes to hit an intraday high of Rs 704 on Wednesday, after the company said its subsidiary signed a long-term radio-pharma business deal in the US. In a filing to the Bombay Stock Exchange or BSE, Jubilant Life Sciences said its "wholly-owned subsidiary Jubilant Pharma, through one of its units, Jubilant DraxImage Montreal Canada (JDI), has signed long-term cont...